BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2134688)

  • 1. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology.
    Tannenbaum SR
    Princess Takamatsu Symp; 1990; 21():351-60. PubMed ID: 2134688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
    Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of bladder cancer.
    Vineis P; Martone T
    Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
    Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
    Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers.
    Hsu TM; Zhang YJ; Santella RM
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):193-9. PubMed ID: 9138663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.
    Talaska G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2003 May; 21(1):29-43. PubMed ID: 12826031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenyl.
    Jiang W; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1999 May; 156(3):187-94. PubMed ID: 10222311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of exposure and susceptibility to aromatic amine carcinogens.
    Kadlubar FF; Talaska G; Lang NP; Benson RW; Roberts DW
    IARC Sci Publ; 1988; (89):166-74. PubMed ID: 3198199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts.
    Weston A; Willey JC; Manchester DK; Wilson VL; Brooks BR; Choi JS; Poirier MC; Trivers GE; Newman MJ; Mann DL
    IARC Sci Publ; 1988; (89):181-9. PubMed ID: 3143667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biomarkers of gentotoxic risk and metabolic polymorphism].
    Pavanello S; Clonfero E
    Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
    Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
    Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dosimetry of aromatic amines in human populations.
    Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.